You probably assumed that a lifetime ban from an industry means exactly that. No more deals, no more trading, no more showing up in that world at all. A new federal filing says that assumption didn’t hold for Martin Shkreli, and the government wants a judge to do something about it.
What the FTC is accusing him of
The FTC and seven states have asked the U.S. District Court for the Southern District of New York to hold Shkreli in contempt. According to the FTC’s press release, dated October 13, the motion alleges he traded stock in more than 60 pharmaceutical companies. It also alleges he ran short-selling livestream campaigns on YouTube, X and Reddit. Both, the FTC says, violated a lifetime ban on working in the pharmaceutical industry.
This is an allegation in a pending motion, not a court ruling. File it under “accused of” for now, not “did.” Nobody has found Shkreli in contempt yet; the FTC and the joining states are asking a judge to.
The ban he’s accused of ignoring
That lifetime ban came out of a 2022 case against Shkreli. It also left him owing more than $64 million in disgorgement — money a court ordered him to hand over, which the FTC says he still hasn’t paid. If you’ve ever assumed a “lifetime ban” from a court means someone is actually gone from an industry, this is the part worth sitting with. The ban was supposed to be the part of that order with no gray area. Not an advisor. Not a consultant. Not a public commentator on pharma stocks. Just out.
If the new allegations hold up, the ban did its job on paper and nothing else. Shkreli just moved the activity onto a camera instead of a trading desk. You’d have had no way of knowing that from the court record alone.
How the alleged scheme is said to have worked
According to the motion, Shkreli livestreamed commentary on pharmaceutical stocks while actively trading them. That built an audience around exactly the kind of insider-feeling market talk his ban was meant to shut down. Short-selling — betting a stock’s price will fall — is a legal strategy on its own, the kind you could use through an ordinary brokerage account. What makes this different, per the FTC’s allegation, is simple: a person explicitly barred from the industry is accused of using that industry’s own stocks as his content.
Seven states joining the FTC on one motion is itself a signal. It tells you this isn’t one agency chasing a grudge.
What happens if the court agrees
The FTC’s filing asks for a contempt finding, forced divestment of the stocks in question, and disgorgement of any trading profits with interest on top. It also asks for escalating penalties if the conduct continues. None of that happens automatically. It’s what the government is requesting, and a judge still has to weigh in.
Whatever the court decides, one lesson travels regardless: a ban on paper only works if someone’s actually checking, and apparently nobody checked a livestream feed until now. You don’t have to follow pharma stocks, or know who Martin Shkreli is, to take something from that. “Banned for life” and “actually stopped” aren’t always the same sentence — in finance, or anywhere else you’re trusting someone to police themselves without you watching.
This article was produced with the assistance of AI and reviewed by Womens Overview editors prior to publication.